(Q36869597)

16 August 2017

title

Recursive partitioning analysis of 1592 patients on four Radiation Therapy Oncology Group studies in inoperable non-small cell lung cancer (English)

1 reference

16 August 2017

1 reference

Scott C

1

1 reference

16 August 2017

Sause WT

2

1 reference

16 August 2017

Byhardt R

3

1 reference

16 August 2017

Marcial V

4

1 reference

16 August 2017

Pajak TF

5

1 reference

16 August 2017

Herskovic A

6

1 reference

16 August 2017

Cox JD

7

1 reference

16 August 2017

publication date

1 June 1997

1 reference

16 August 2017

1 reference

16 August 2017

volume

17 Suppl 1

1 reference

16 August 2017

page(s)

S59-74

1 reference

A new international staging system for lung cancer

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900640-5

7 January 2021

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900640-5

7 January 2021

Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: Results of a prospective randomized trial conducted by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900640-5

7 January 2021

A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900640-5

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900640-5

7 January 2021

A Qualitative Discrepancy between Censored Data Rank Tests

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900640-5

7 January 2021

A stagewise rejective multiple test procedure based on a modified Bonferroni test

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900640-5

7 January 2021

Measures of explained variation for survival data

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900640-5

7 January 2021

Phase II Trial of Combination Chemotherapy and Irradiation in Non-Small-Cell Lung Cancer, Radiation Therapy Oncology Group 88–04

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900640-5

7 January 2021

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900640-5

7 January 2021

Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900640-5

7 January 2021

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900640-5

7 January 2021

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900640-5

7 January 2021

Small-cell carcinoma of the lung: derivation of a prognostic staging system.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900640-5

7 January 2021

What do we need beyond TNM?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900640-5

7 January 2021

10.1016/S0169-5002(97)00640-5

Identifiers

DOI

1 reference

16 August 2017

1 reference